Brother Technology: PEEK is a key application field of hydroquinone, and the company is still in the promotion stage. Brother Technology (002562) said on the interactive platform that the company's hydroquinone products are mainly sold to domestic mainstream acrylic acid producers, and PEEK is a key application field of hydroquinone, and the company is still in the promotion stage; The production capacity of the second phase project of hydroquinone is being released as planned. At present, the company has a production capacity of 20,000 tons of catechol and hydroquinone. Regarding the industrial chain extension plan, the company will carry out relevant work according to the strategic plan and disclose information in time according to the requirements of information disclosure.The concept of PEEK materials fell by more than 10%, and the concept of PEEK materials fell by more than 10%, while Sinoresearch, Zhongxin Fluoride, Shuanglin, Walter and Jusailong fell.The South Korean prosecutor once again summoned Brother Lv Yinxiong, the anti-espionage commander of the Ministry of National Defense. On the 12th local time, the South Korean prosecutor once again summoned Brother Lv Yinxiong, the core figure of the "emergency martial law incident". (CCTV News)
Retail stocks rose again, and Maoye Commercial, Zhongbai Group, Youa Shares, Liangpin Shop, Dashang Shares, Dongbai Group and other collective daily limit.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.Treasury futures collectively opened higher, with 30-year main contracts up 0.21%, 30-year main contracts up 0.21%, 10-year main contracts up 0.09%, 5-year main contracts up 0.03% and 2-year main contracts up 0.01%.
Ordinary people invested in the establishment of a Chinese medicine comprehensive clinic company. The enterprise search APP shows that Yangzhong Ordinary People Chinese Medicine Comprehensive Clinic Co., Ltd. was recently established, with lin li as the legal representative and a registered capital of 100,000 yuan. Its business scope includes: drug retail; Chinese medicine clinic service. Enterprise investigation shows that the company is indirectly wholly owned by ordinary people.Guangxi Securities Regulatory Bureau issued a warning letter to Xinxunda and relevant responsible persons. According to the website of the CSRC, Guangxi Securities Regulatory Bureau issued a decision on taking measures to issue a warning letter to Guangxi Xinxunda Technology Group Co., Ltd. and relevant responsible persons. Among them, it is mentioned that Xinxunda has some problems, such as the occupation of non-operating funds of related parties and the failure to disclose them in time, the failure to review and disclose the external financial assistance in time, and the irregular management of insider registration. The Guangxi Securities Regulatory Bureau decided to issue warning letters to Xinxunda, Wu Chenghua, Wang Fabin, Yan Ming, Chen Gong, Li Yangang and Ye Yanzhen.The net outflow of the main market exceeded 10 billion.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide